Compare PACK & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PACK | BME |
|---|---|---|
| Founded | 1972 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | Trusts Except Educational Religious and Charitable |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 485.2M | 547.5M |
| IPO Year | 2017 | 2005 |
| Metric | PACK | BME |
|---|---|---|
| Price | $3.25 | $38.85 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $6.50 | N/A |
| AVG Volume (30 Days) | ★ 628.5K | 34.3K |
| Earning Date | 03-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $395,000,000.00 | N/A |
| Revenue This Year | $11.99 | N/A |
| Revenue Next Year | $8.16 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 7.08 | N/A |
| 52 Week Low | $2.91 | $34.18 |
| 52 Week High | $6.31 | $42.74 |
| Indicator | PACK | BME |
|---|---|---|
| Relative Strength Index (RSI) | 25.81 | 18.74 |
| Support Level | N/A | $37.91 |
| Resistance Level | $3.79 | $42.55 |
| Average True Range (ATR) | 0.31 | 0.58 |
| MACD | -0.07 | -0.27 |
| Stochastic Oscillator | 1.16 | 2.23 |
Ranpak Holdings Corp is a provider of environmentally sustainable, systems-based, product protection solutions for e-Commerce and industrial supply chains. The company offers a full suite of protective packaging systems and paper consumables. Geographically, it derives a majority of its revenue from Europe/Asia. The group generates revenue by providing its PPS systems and paper consumables to customers, which include direct end-users and a network of exclusive paper packaging solution distributors, and by providing end-of-line automation systems that solve challenges, including optimization, customization, and efficiency. It has two segments, North America and Europe/Asia.
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.